Dr. Lal Ventures, a subsidiary, completed its 30% stake subscription in Neuome Technologies.

Dr. Lal Path Labs Ltd.LALPATHLAB · Filed with the exchange

Neuome is now an associate company, expanding Dr. Lal PathLabs' strategic reach.

No comments yet. Be the first.

More from Dr. Lal Path Labs Ltd.

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.